Bosutinib plus capecitabine for selected advanced solid tumours: results of a phase 1 dose-escalation study
Crossref DOI link: https://doi.org/10.1038/bjc.2014.508
Published Online: 2014-10-07
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Isakoff, S J
Wang, D
Campone, M
Calles, A
Leip, E
Turnbull, K
Bardy-Bouxin, N
Duvillié, L
Calvo, E
License valid from 2014-10-07
Article History
Received: 23 December 2013
Revised: 1 July 2014
Accepted: 25 August 2014
First Online: 7 October 2014